HOME > multiple-sclerosis > ms-drugs > copaxone

Multiple Sclerosis (MS) Drugs

| Avonex | Betaseron | Betaferon | Copaxone | Rebif |

 

Copaxone ® (glatiramer acetate)

MS Drugs - Copaxone ® Efficacy (Effectiveness of Copaxone ®)

How effective is Copaxone ®?

% of patients relapse free at 2 years
Placebo Copaxone ®
27% 34%

 

Number of patients progression free† completing 2 years of Copaxone ®
% of patients progression free at 2 years Placebo Copaxone ®
75% 78%

 

Mean relapse rate
Mean relapse rate over 2 years Placebo Copaxone ®
1.68 1.19

 

Average time to first relapse
Average number of days till first relapse Placebo Copaxone ®
198 days 287 days

 

† Progression is defined as an increase in at least 1 point in the DSS (Kurtzke Expanded Disability Scale) for at least 3 consecutive months

Ref: Copaxone® prescribing information

 

 

 

Multiple Sclerosis

2002 – A patient with Multiple Sclerosis can expect to live to average population life-expectancy minus seven years (mean life expectancy - 7 years).

Early Symptoms

The nature of multiple sclerosis and the vagueness of a symptom appearing here or there over time, without any apparent connection means there is a lack of data on what can accurately be considered as early symptom of multiple sclerosis... Read More